Dr. Rob Myers, MD, FRCPC, awarded Queen Elizabeth II Diamond Jubilee Award
By Todd O’Keefe
Snyder Institute member, Dr. Rob Myers, MD, MSc, FRCPC, was recently recognized for his contribution to impacting and changing the lives of people suffering from chronic liver disease. The Canadian Liver Foundation (CLF) presented him with a Queen Elizabeth II Diamond Jubilee Medal for his efforts in leading discoveries for the more than 30 million Canadians living with liver disease. He is one of only 30 individuals who received this national award from the CLF for his contributions.
His current research focuses on examining the epidemiology and outcomes of various chronic liver diseases, including hepatitis C. Myers is also investigating novel, non-invasive methods of evaluating liver fibrosis or scarring as an alternative to liver biopsy in patients with liver disease.
“It’s a great honour to receive the Queen Elizabeth II Diamond Jubilee Award, and in particular, being nominated by the Canadian Liver Foundation (CLF),” he says. “It does outstanding work to raise awareness and educate the public about liver disease. The CLF advocates on behalf of patients and their families, and supports liver-related research.
“These are important objectives that I’ve tried to focus on during my academic and clinical activities.”
Myers states that determining who is at risk of liver disease and the factors that affect prognosis will further his research in improving the clinical outcomes of patients with liver disease. His studies of non-invasive markers of liver fibrosis help guide clinicians how best to safely evaluate their patients by avoiding liver biopsy, and hopefully, potentially serious complications.